tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Sarcoidosis D012507 13 associated lipids
Hepatolenticular Degeneration D006527 3 associated lipids
Hyperglycemia D006943 21 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Gao L et al. Synergistic Effects of Tacrolimus and Azoles against Exophiala dermatitidis. 2017 Antimicrob. Agents Chemother. pmid:28923863
Steinbach WJ et al. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. 2004 Antimicrob. Agents Chemother. pmid:15105118
Onyewu C et al. Targeting the calcineurin pathway enhances ergosterol biosynthesis inhibitors against Trichophyton mentagrophytes in vitro and in a human skin infection model. 2007 Antimicrob. Agents Chemother. pmid:17664323
Morikawa K et al. Immunosuppressive activity of fosfomycin on human T-lymphocyte function in vitro. 1993 Antimicrob. Agents Chemother. pmid:7509146
Sun S et al. In vitro interactions between tacrolimus and azoles against Candida albicans determined by different methods. 2008 Antimicrob. Agents Chemother. pmid:18056277
Roy J et al. The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication. 2002 Antimicrob. Agents Chemother. pmid:12384349
Sugita T et al. A new calcineurin inhibitor, pimecrolimus, inhibits the growth of Malassezia spp. 2006 Antimicrob. Agents Chemother. pmid:16870799
Dang W et al. Inhibition of Calcineurin or IMP Dehydrogenase Exerts Moderate to Potent Antiviral Activity against Norovirus Replication. 2017 Antimicrob. Agents Chemother. pmid:28807916
Pea F et al. Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients. 2008 Antivir. Ther. (Lond.) pmid:18771060
Ginestà MM et al. Acute xenograft rejection, late xenograft rejection and long term survival xenografts in the hamster-to-rat heart transplantation model: histological characterisation under low-dose of FK506. 2002 APMIS pmid:12583441
Kuo WW et al. Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II. 2006 Apoptosis pmid:16699953
Rapak A et al. Apoptosis of lymphoma cells is abolished due to blockade of cytochrome c release despite Nur77 mitochondrial targeting. 2007 Apoptosis pmid:17701362
Kabat-Koperska J et al. The influence of exposure to immunosuppressive treatment during pregnancy on renal function and rate of apoptosis in native kidneys of female Wistar rats. 2016 Apoptosis pmid:27586504
Kemper K et al. Targeting colorectal cancer stem cells with inducible caspase-9. 2012 Apoptosis pmid:22223359
Chen D et al. Improvement of FK506 production in Streptomyces tsukubaensis by genetic enhancement of the supply of unusual polyketide extender units via utilization of two distinct site-specific recombination systems. 2012 Appl. Environ. Microbiol. pmid:22582065
Mo S et al. Roles of fkbN in positive regulation and tcs7 in negative regulation of FK506 biosynthesis in Streptomyces sp. strain KCTC 11604BP. 2012 Appl. Environ. Microbiol. pmid:22267670
Kallscheuer N et al. Single-Domain Peptidyl-Prolyl cis/trans Isomerase FkpA from Corynebacterium glutamicum Improves the Biomass Yield at Increased Growth Temperatures. 2015 Appl. Environ. Microbiol. pmid:26341203
Barreiro C and Martínez-Castro M Trends in the biosynthesis and production of the immunosuppressant tacrolimus (FK506). 2014 Appl. Microbiol. Biotechnol. pmid:24272367
Salehi-Najafabadi Z et al. The gamma-butyrolactone receptors BulR1 and BulR2 of Streptomyces tsukubaensis: tacrolimus (FK506) and butyrolactone synthetases production control. 2014 Appl. Microbiol. Biotechnol. pmid:24562179
Kimura T et al. N-glycosylation is involved in the sensitivity of Saccharomyces cerevisiae to HM-1 killer toxin secreted from Hansenula mrakii IFO 0895. 1999 Appl. Microbiol. Biotechnol. pmid:10091323
Song K et al. Engineering of the LysR family transcriptional regulator FkbR1 and its target gene to improve ascomycin production. 2017 Appl. Microbiol. Biotechnol. pmid:28349163
Mo S et al. Application of a combined approach involving classical random mutagenesis and metabolic engineering to enhance FK506 production in Streptomyces sp. RM7011. 2013 Appl. Microbiol. Biotechnol. pmid:23053074
Wang J et al. Comparative proteomic and metabolomic analysis of Streptomyces tsukubaensis reveals the metabolic mechanism of FK506 overproduction by feeding soybean oil. 2017 Appl. Microbiol. Biotechnol. pmid:28175948
Ordóñez-Robles M et al. Target genes of the Streptomyces tsukubaensis FkbN regulator include most of the tacrolimus biosynthesis genes, a phosphopantetheinyl transferase and other PKS genes. 2016 Appl. Microbiol. Biotechnol. pmid:27357227
Salehi-Najafabadi Z et al. Characterisation of a γ-butyrolactone receptor of Streptomyces tacrolimicus: effect on sporulation and tacrolimus biosynthesis. 2011 Appl. Microbiol. Biotechnol. pmid:21792593
Ma D et al. Manipulating the expression of SARP family regulator BulZ and its target gene product to increase tacrolimus production. 2018 Appl. Microbiol. Biotechnol. pmid:29666890
Ordóñez-Robles M et al. Streptomyces tsukubaensis as a new model for carbon repression: transcriptomic response to tacrolimus repressing carbon sources. 2017 Appl. Microbiol. Biotechnol. pmid:28983826
Kim DH et al. Mutational biosynthesis of tacrolimus analogues by fkbO deletion mutant of Streptomyces sp. KCTC 11604BP. 2013 Appl. Microbiol. Biotechnol. pmid:23392766
Martínez-Castro M et al. Taxonomy and chemically semi-defined media for the analysis of the tacrolimus producer 'Streptomyces tsukubaensis'. 2013 Appl. Microbiol. Biotechnol. pmid:22990582
Pavan M et al. Polyomavirus associated nephropathy presenting five years after kidney transplantation. 2011 Arab J Nephrol Transplant pmid:21999857
Okudaira H et al. Control of allergic diseases by regulation of cytokine gene transcription. 1997 Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M pmid:9383912
Kreuter A et al. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study. 2006 Arch Dermatol pmid:16983001
Travis LB et al. Successful treatment of vitiligo with 0.1% tacrolimus ointment. 2003 Arch Dermatol pmid:12756092
Lepe V et al. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. 2003 Arch Dermatol pmid:12756094
Ruzicka T et al. Tacrolimus: the drug for the turn of the millennium? 1999 Arch Dermatol pmid:10328199
Laffitte E et al. Erosive pustular dermatosis of the scalp: treatment with topical tacrolimus. 2003 Arch Dermatol pmid:12810500
Chu J et al. Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid. 2003 Arch Dermatol pmid:12810523
Allen A et al. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. 2001 Arch Dermatol pmid:11405764
Qureshi AA and Fischer MA Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks. 2006 Arch Dermatol pmid:16702502
Eichenfield LF et al. 1% pimecrolimus cream for atopic dermatitis. 2003 Arch Dermatol pmid:14568846
Thiers BH Topical tacrolimus: treatment failure in a patient with alopecia areata. 2000 Arch Dermatol pmid:10632221
Rotunda AM et al. Hyperkeratotic plaques on the palms and soles. Palmoplantar lichen planus, hyperkeratotic variant. 2004 Arch Dermatol pmid:15492196
Laffitte E and Panizzon RG Is topical tacrolimus really an effective therapy for Hailey-Hailey disease? 2004 Arch Dermatol pmid:15492199
Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study. The European FK 506 Multicentre Psoriasis Study Group. 1996 Arch Dermatol pmid:8629845
Bigby M A thorough systematic review of treatments for atopic eczema. 2001 Arch Dermatol pmid:11735714
Bernard LA et al. A rosacea-like granulomatous eruption in a patient using tacrolimus ointment for atopic dermatitis. 2003 Arch Dermatol pmid:12588240
Jegasothy BV et al. Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. 1992 Arch Dermatol pmid:1376102
Van Leent EJ et al. Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. 1998 Arch Dermatol pmid:9681343
Mandelin J et al. Effect of oral acetylsalicylic acid on burning caused by tacrolimus ointment in patients with atopic dermatitis. 2010 Arch Dermatol pmid:20956662
Lener EV et al. Successful treatment of erosive lichen planus with topical tacrolimus. 2001 Arch Dermatol pmid:11295919
Mehrabi D and Pandya AG A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo. 2006 Arch Dermatol pmid:16847214
Colebunders R et al. HIV eosinophilic folliculitis in Uganda. 2006 Arch Dermatol pmid:16847219
Lebwohl M et al. Proven efficacy of tacrolimus for facial and intertriginous psoriasis. 2005 Arch Dermatol pmid:16172314
Neill SM and Lewis FM Vulvovaginal lichen planus: a disease in need of a unified approach. 2008 Arch Dermatol pmid:19015426
Gorman CR and White SW Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream. 2005 Arch Dermatol pmid:16172323
Cooper SM et al. Vulvovaginal lichen planus treatment: a survey of current practices. 2008 Arch Dermatol pmid:19015433
Heffernan MP et al. 0.1% tacrolimus ointment in the treatment of discoid lupus erythematosus. 2005 Arch Dermatol pmid:16172325
Lally A et al. Penile pyoderma gangrenosum treated with topical tacrolimus. 2005 Arch Dermatol pmid:16172330
Passeron T et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. 2004 Arch Dermatol pmid:15381545
Bunker CB et al. Topical tacrolimus, genital lichen sclerosus, and risk of squamous cell carcinoma. 2004 Arch Dermatol pmid:15381566
Le Cleach L et al. Is topical monotherapy effective for localized pyoderma gangrenosum? 2011 Arch Dermatol pmid:21242400
Pomerantz RG et al. Posttransplant cutaneous T-cell lymphoma: case reports and review of the association of calcineurin inhibitor use with posttransplant lymphoproliferative disease risk. 2010 Arch Dermatol pmid:20479299
Ehst BD and Warshaw EM Alcohol-induced application site erythema after topical immunomodulator use and its inhibition by aspirin. 2004 Arch Dermatol pmid:15313828
Sagransky MJ et al. A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. 2010 Arch Dermatol pmid:21173330
Laino L and DiCarlo A Palmoplantar pustular psoriasis: clinical and video thermographic evaluation before and after topical tacrolimus treatment. 2011 Arch Dermatol pmid:21690553
Eiling E et al. Pimecrolimus: a novel treatment for cetuximab-induced papulopustular eruption. 2008 Arch Dermatol pmid:18794482
Byrd JA et al. Response of oral lichen planus to topical tacrolimus in 37 patients. 2004 Arch Dermatol pmid:15611431
Santos-Juanes J et al. Topical tacrolimus: an effective therapy for Zoon balanitis. 2004 Arch Dermatol pmid:15611442
Milingou M et al. Alcohol intolerance and facial flushing in patients treated with topical tacrolimus. 2004 Arch Dermatol pmid:15611445
Singh MN et al. Solitary cutaneous nodule in an immunocompromised patient. 2007 Arch Dermatol pmid:18087016
Ng W and Ikeda S Mount Tsukuba and the origin of tacrolimus. 2009 Arch Dermatol pmid:19289758
Sardana K et al. Effect of tacrolimus on vitiligo in absence of UV radiation exposure. 2007 Arch Dermatol pmid:17224558
Carroll CL et al. Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment. 2005 Arch Dermatol pmid:15655140
Patel RR et al. The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis. 2003 Arch Dermatol pmid:12975161
Nagao K et al. A case of generalized pustular psoriasis treated with topical tacrolimus. 2003 Arch Dermatol pmid:12975175
Yan AC et al. The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study. 2010 Arch Dermatol pmid:20083693
Ciurea AM et al. Complete and durable clinical response of malignant pyoderma to tacrolimus in combination with dapsone and prednisone. 2010 Arch Dermatol pmid:20083712
Castelo-Soccio L et al. Induced lentiginosis with use of topical calcineurin inhibitors. 2012 Arch Dermatol pmid:22710469
Ward KM et al. Eyelash trichomegaly associated with systemic tacrolimus. 2006 Arch Dermatol pmid:16490862
Ostovari N et al. Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure. 2006 Arch Dermatol pmid:16490866
Mikhail M et al. Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus. 2008 Arch Dermatol pmid:18427063
Chapman MS et al. 0.1% tacrolimus ointment for the treatment of intertrigo. 2005 Arch Dermatol pmid:15967933
Olivier V et al. Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. 2002 Arch Dermatol pmid:12374539
Böhm M et al. Successful treatment of anogenital lichen sclerosus with topical tacrolimus. 2003 Arch Dermatol pmid:12873890
Reitamo S et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. 2000 Arch Dermatol pmid:10926735
Sugiura H et al. Long-term efficacy of tacrolimus ointment for recalcitrant facial erythema resistant to topical corticosteroids in adult patients with atopic dermatitis. 2000 Arch Dermatol pmid:10926750
Byrd JA et al. Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus. 2004 Arch Dermatol pmid:15210463
Shah KN and Yan AC Low but detectable serum levels of tacrolimus seen with the use of very dilute, extemporaneously compounded formulations of tacrolimus ointment in the treatment of patients with netherton syndrome. 2006 Arch Dermatol pmid:17043199
Antille C et al. Induction of rosaceiform dermatitis during treatment of facial inflammatory dermatoses with tacrolimus ointment. 2004 Arch Dermatol pmid:15096374
Banky JP et al. Successful treatment of epidermolysis bullosa pruriginosa with topical tacrolimus. 2004 Arch Dermatol pmid:15262686
Passeron T et al. Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood. 2007 Arch Dermatol pmid:17438179
Bruce A and Rogers RS New and old therapeutics for oral ulcerations. 2007 Arch Dermatol pmid:17438186
Qureshi A and Fischer MA Topical calcineurin inhibitors revisited. 2007 Arch Dermatol pmid:17438195
Carroll PB et al. Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: rationale and preliminary results. 1994 Arch Dermatol pmid:7526802
Rapaport MJ Topical tacrolimus. 2005 Arch Dermatol pmid:16301404
Cheng A and Mann C Oral erosive lichen planus treated with efalizumab. 2006 Arch Dermatol pmid:16785369
Mackelfresh J et al. Combination therapy of doxycycline and topical tacrolimus for venous ulcers. 2005 Arch Dermatol pmid:16301410
Sniezek PJ et al. Annular atrophic plaques on the arms of a 57-year-old woman. 2006 Arch Dermatol pmid:16785386
Allen DM and Esterly NB Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis. 2002 Arch Dermatol pmid:12225004
Hall VC et al. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. 2003 Arch Dermatol pmid:12925404